Sequential Intraperitoneal Topotecan and Oral Etoposide Chemotherapy in Recurrent Platinum-Resistant Ovarian Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sequential Intraperitoneal Topotecan and Oral Etoposide Chemotherapy in Recurrent Platinum-Resistant Ovarian Carcinoma

Published:2004-09-15 Issue:18 Volume:10 Page:6080-6085
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Sood Anil K.,Lush Richard,Geisler John P.,Shahin Mark S.,Sanders Linda,Sullivan Dan,Buller Richard E.,Sorosky Joel I.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergy between human DNA ligase I and topoisomerase 1 unveils new therapeutic strategy for the management of colorectal cancer;Journal of Biomolecular Structure and Dynamics;2024-01-05

2. Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies;Drugs;2023-01-12

3. Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics;Clinical Pharmacokinetics;2012-04

4. Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer;Anti-Cancer Drugs;2012-03

5. Overcoming platinum resistance in ovarian carcinoma;Expert Opinion on Investigational Drugs;2010-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP